Glucotrack (GCTK) Research & Development (2010 - 2026)
Glucotrack (GCTK) reported Research & Development of $2.02 million for Q2 2026, down 36.0% from $3.15 million a year earlier.
Powered by 
Analysis
Glucotrack (GCTK) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Glucotrack's Research & Development came in at $9.96 million, up 13.4% year-over-year; for FY2025, it was $9.81 million, up 3.3% from FY2024.
- Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 45.0% (FY2020 to FY2025).
- By year, Research & Development came in at $9.5 million in FY2024 (+101.9%), $4.7 million in FY2023 (+139.1%), $1.97 million in FY2022 (+8.7%) and $1.81 million in FY2021 (+18.1%).
- Five-year quarterly Research & Development spans a low of $434,000 in Q3 2022 and a high of $3.59 million in Q2 2024.
- Year over year, Research & Development gained in two of the last seven quarters, with growth averaging 1.1%.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 472.4%); the low point was Q2 2026 (a decline of 36.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Glucotrack | 581,053.86 | -25.35 Mn | - | 2.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 733,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 321,000.00 |
API Access
Glucotrack Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GCTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GCTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GCTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();